Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Preformed Line Products
PLPC
$1.75B
| $878K | ﹤0.01% |
6,835
-231
| -3% | -$29.6K |
|
1702
Upstart Holdings
UPST
$2.63B
| $876K | ﹤0.01% |
32,609
+15
| +0% | +$444 |
|
1703
US Physical Therapy
USPH
$1.2B
| $875K | ﹤0.01% |
7,764
| – | – |
|
1704
Tronox
TROX
$932M
| $875K | ﹤0.01% |
50,459
+3
| +0% | +$44 |
|
1705
CAVA Group
CAVA
$7.6B
| $872K | ﹤0.01% |
12,448
-334
| -3% | -$17.9K |
|
1706
Texas Pacific Land
TPL
$27.8B
| $871K | ﹤0.01% |
4,518
-9
| -0.2% | -$1.54K |
|
1707
Plug Power
PLUG
$2.87B
| $866K | ﹤0.01% |
252,128
+60
| +0% | +$223 |
|
1708
Crescent Energy
CRGY
$3.79B
| $865K | ﹤0.01% |
72,678
-12,703
| -15% | -$143K |
|
1709
Agios Pharmaceuticals
AGIO
$1.79B
| $864K | ﹤0.01% |
29,581
+7
| +0% | +$187 |
|
1710
Cohen & Steers
CNS
$4.23B
| $863K | ﹤0.01% |
11,222
| – | – |
|
1711
Robert Half
RHI
$3.87B
| $863K | ﹤0.01% |
10,890
+1
| +0% | +$81 |
|
1712
ADT
ADT
$5.58B
| $862K | ﹤0.01% |
128,362
+50,006
| +64% | +$332K |
|
1713
Agilysys
AGYS
$2.97B
| $862K | ﹤0.01% |
10,229
-5
| -0% | -$404 |
|
|
STR
1714
DELISTED
Sitio Royalties
STR
| $861K | ﹤0.01% |
34,848
+1
| +0% | +$23 |
|
1715
Semtech
SMTC
$11B
| $861K | ﹤0.01% |
31,314
+2
| +0% | +$43 |
|
1716
Kennametal
KMT
$2.59B
| $860K | ﹤0.01% |
34,456
+2
| +0% | +$49 |
|
1717
Zeta Global
ZETA
$5.38B
| $859K | ﹤0.01% |
78,735
+1
| +0% | +$10 |
|
1718
Compass
COMP
$8.51B
| $858K | ﹤0.01% |
238,703
+126,869
| +113% | +$448K |
|
1719
Levi Strauss
LEVI
$9.44B
| $856K | ﹤0.01% |
42,839
+14
| +0% | +$243 |
|
1720
Oscar Health
OSCR
$9.41B
| $855K | ﹤0.01% |
57,486
+53
| +0.1% | +$726 |
|
|
HTO
1721
H2O America
HTO
$2.57B
| $855K | ﹤0.01% |
15,098
+1
| +0% | +$59 |
|
1722
Southwest Airlines
LUV
$22B
| $854K | ﹤0.01% |
29,277
-57
| -0.2% | -$1.76K |
|
1723
BCE
BCE
$20.2B
| $854K | ﹤0.01% |
25,098
| – | – |
|
1724
CVR Energy
CVI
$3.58B
| $852K | ﹤0.01% |
23,892
+9,607
| +67% | +$319K |
|
1725
RLJ Lodging Trust
RLJ
$1.86B
| $851K | ﹤0.01% |
71,998
+3
| +0% | +$35 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.